---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-044103"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T16:45:48.628895+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# BioMarin amends bylaws to adopt majority voting for directors and tighten advance notice provisions

## Summary
- Uncontested director elections now require 'for' votes to exceed 'against' votes (majority voting standard).
- Advance notice deadlines clarified; stockholder must appear at meeting or proposal is disregarded.
- Stockholders must update disclosure information as of record date and 10 days before meeting.
- Company may request information on nominee independence; substitute nominees require full disclosure.
- Officers may be removed by majority of directors present at a meeting with a quorum.

## SEC filing metadata
- accession: 0001193125-25-044103
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/0001193125-25-044103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/d38831d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-044103
- JSON: https://secwatch.observer/filing/0001193125-25-044103.json
- Plain text: https://secwatch.observer/filing/0001193125-25-044103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.